Lọc theo
Individuals with prediabetes appear to be at an elevated risk of developing myocardial infarction (MI) as well as requiring coronary interventions, according to a study presented at ENDO 2022.
Salivary levels of the inflammatory biomarker immunoglobulin A (IgA) appear to be significantly suppressed in type 1 diabetes mellitus (DM) patients with neuropathy (DMN), reports a recent study.
Reducing sedentary behaviour (SB) by about an hour – without intentionally incorporating exercise or any moderate-to-vigorous physical activity (MVPA) into a daily regimen – improved cardiometabolic outcomes in adults with metabolic syndrome (MetS), a Finnish study suggests.
Once-weekly treatment with tirzepatide in adults with obesity appears to yield substantial and sustained reductions in body weight, according to the phase III SURMOUNT-1 trial.
Implementation of an integrated care team (ICT) in primary care results in enhanced clinical and process outcomes relative to usual care (UC), with more patients who have noncommunicable disease achieving treatment goals at 1 year, a Singapore study has shown.
In patients with type 2 diabetes mellitus (T2DM), chronic hepatitis C and fatty liver appear to worsen the risk of cardiovascular events, a recent Taiwan study has found.
Safety analysis of the phase III MAESTRO-NAFLD-1 trial presented at ILC 2022 demonstrated the potential of resmetirom as a treatment for patients with non-alcoholic steatohepatitis (NASH) who have liver fibrosis.
Individuals with high body mass index (BMI) often eat delivery and takeaway meals, while those with low BMI and percent body fat usually consume homecooked meals, a UK study has found.
A low-carbohydrate, high-fat (LCHF) diet averts disease progression in patients with nonalcoholic fatty liver disease (NAFLD) in a new study presented at ILC 2022.
Among older adults with prediabetes, glycated haemoglobin levels (HbA1c), body mass index (BMI), and β-cell function appear to be significantly associated with response to exercise.
